ORAMORPH Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Oramorph, and what generic alternatives are available?
Oramorph is a drug marketed by Xanodyne Pharms Inc and is included in one NDA.
The generic ingredient in ORAMORPH is morphine sulfate. There are twenty-three drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Oramorph
A generic version of ORAMORPH was approved as morphine sulfate by HOSPIRA on September 30th, 1992.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ORAMORPH?
- What are the global sales for ORAMORPH?
- What is Average Wholesale Price for ORAMORPH?
Summary for ORAMORPH
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | ORAMORPH at DailyMed |
US Patents and Regulatory Information for ORAMORPH
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Xanodyne Pharms Inc | ORAMORPH SR | morphine sulfate | TABLET, EXTENDED RELEASE;ORAL | 019977-004 | Nov 23, 1994 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Xanodyne Pharms Inc | ORAMORPH SR | morphine sulfate | TABLET, EXTENDED RELEASE;ORAL | 019977-003 | Aug 15, 1991 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Xanodyne Pharms Inc | ORAMORPH SR | morphine sulfate | TABLET, EXTENDED RELEASE;ORAL | 019977-001 | Aug 15, 1991 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Xanodyne Pharms Inc | ORAMORPH SR | morphine sulfate | TABLET, EXTENDED RELEASE;ORAL | 019977-002 | Aug 15, 1991 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
